Envision Scientific is an organization involved in Research and Development activities in the field of advanced cardiovascular devices. The company has developed various technological superior devices and drug delivery systems which increase levels of safety and effectiveness of treatments.

  • Envision Scientific was selected in Red Herring 2013 Top companies in Asia and was selected as Top 100 Winner. The Award was presented to its CEO Manish Doshi at Hong Kong, on 5th September 2013.

    RED HERRING AWARDS 2013

    Envision Scientific

  • PCR 2010, Paris FRANCE : Envision Scientific selected to present its novel NANOACTIVE (Nanocarrier based drug delivery) Technology in Innovation Arena. The technology generates keen interest from the Scientific Community as it is the first to delivery drug in polymer free encapsulated matrix.

    Manish Doshi

    CEO, Envision Scientific

  • CRT 2012, Miami USA : Envision Scientific’s FOCUS np Technology presented at Cardiovasculer Resarch Technologies Meeting by Prof. Patrick Serruys-  Thoraxcenter, Rotterdam, The Netherlands.

    Manish Doshi

    CEO, Envision Scientific

  • TCT 2012, Miami USA : Envision Scientific presents its first update on NANOACTIVE FIM-IN Clinical study with FOCUS np Nanocarrier based coronary stent system. The Presentation was done by Dr. Ashok Seth - Principal Investigator, Fortis Escorts Heart Institute, New Delhi.

    Manish Doshi

    CEO, Envision Scientific